# FDA Inspection 1197938 - Gadal Laboratories Inc. - February 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/gadal-laboratories-inc/d0f952a9-f2cc-4836-99f8-d784a9c1c4f9
Source feed: FDA_Inspections

> FDA Inspection 1197938 for Gadal Laboratories Inc. on February 17, 2023. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1197938
- Company Name: Gadal Laboratories Inc.
- Inspection Date: 2023-02-17
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1324124 - 2026-06-29](https://www.keypedia.com/records/fda_inspections/gadal-laboratories-inc/f7fd2b1f-0d32-4197-a66a-138293616c4a)
- [FDA Inspection 1324124 - 2026-06-29](https://www.keypedia.com/records/fda_inspections/gadal-laboratories-inc/59e24dd6-3bc7-4c2e-b007-a05f01a85dd5)
- [FDA Inspection 1099170 - 2019-08-09](https://www.keypedia.com/records/fda_inspections/gadal-laboratories-inc/a4bc0228-ab7a-48e8-9210-7a6a1f3f6566)
- [FDA Inspection 976729 - 2016-04-28](https://www.keypedia.com/records/fda_inspections/gadal-laboratories-inc/8a135f1c-f78b-4642-a3b9-654fb3ff8234)
- [FDA Inspection 976729 - 2016-04-28](https://www.keypedia.com/records/fda_inspections/gadal-laboratories-inc/f7a80a8e-7d27-4cbf-8a94-063b8276e81d)

Company: https://www.keypedia.com/companies/gadal-laboratories-inc/ab020b2d-bc0c-4731-bc27-f75fc34163d4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c